Relay Therapeutics Inc
RLAY
NASDAQ
Biotechnology
$19.86
USD
-0.07 (-0.35%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.37B
Volume 1.5M
Price Target
$21.00 – $28.00
USD
The 5 analysts offering 1-year price forecasts have a max estimate of $28.00 and a min estimate of $21.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$25.60
+$4.9 vs prior
Implied Upside
+28.9%
+24.4% vs prior
Analyst Covering
5
-3 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
38%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0.4000 Gap
Median $26.00 vs avg $25.60 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
5 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
1
Buy
4
Hold
0
Sell
0
Strong Sell
0
5 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Robert Burns | HC Wainwright & Co. | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Brad Canino | Guggenheim | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Etzer Darout | BMO Capital | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Silvan Turkcan | JMP Securities | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Dane Leone | Raymond James | Strong Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
